yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33411100-1BB56D68-6437-478D-835A-E55663FE67F9
Q33411100-1BB56D68-6437-478D-835A-E55663FE67F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411100-1BB56D68-6437-478D-835A-E55663FE67F9
Authorising bortezomib treatment prior to reviewing haematology results: a step toward home administration.
P2860
Q33411100-1BB56D68-6437-478D-835A-E55663FE67F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411100-1BB56D68-6437-478D-835A-E55663FE67F9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8c7b9a9f5e84e8c9c40bdafd6b91ed2fa3caa560
P2860
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.